氨甲蝶呤 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "氨甲蝶呤" in Chinese language version.

refsWebsite

Global rank Chinese rank

25nih.gov

4^th place

5^th place

23doi.org

2^nd place

23^rd place

7web.archive.org

1^st place

4semanticscholar.org

11^th place

332^nd place

2books.google.com

3^rd place

8^th place

2nihr.ac.uk

low place

1oxforddictionaries.com

710^th place

776^th place

1merriam-webster.com

209^th place

356^th place

1dictionary.com

794^th place

1,687^th place

1drugs.com

399^th place

208^th place

1europa.eu

68^th place

209^th place

1medscape.com

719^th place

889^th place

1economist.com

254^th place

330^th place

1who.int

195^th place

179^th place

1mshpriceguide.org

low place

5,458^th place

1medicines.org.uk

3,823^rd place

3,456^th place

1hu-berlin.de

2,869^th place

5,608^th place

1archive.org

6^th place

4^th place

1versusarthritis.org

low place

1mayoclinic.org

1,610^th place

2,275^th place

1nice.org.uk

3,258^th place

2,433^rd place

1medicinescomplete.com

low place

9,960^th place

1harvard.edu

18^th place

57^th place

archive.org

Joint Formulary Committee. British National Formulary (BNF) 65. London, UK: Pharmaceutical Press. 2013. ISBN 978-0-85711-084-8.

books.google.com

Sneader, Walter. Drug Discovery: A History. John Wiley & Sons. 2005: 251. ISBN 9780470015520. （原始内容存档于2017-02-16）（英语）.
Bertino JR. Methotrexate: historical aspects. Cronstein BN, Bertino JR (编). Methotrexate. Basel: Birkhäuser. 2000. ISBN 978-3-7643-5959-1. ^{[页码请求]}

dictionary.com

methotrexate. Dictionary.com Unabridged. Random House.

doi.org

Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis. An update. Drugs. January 1994, 47 (1): 25–50. PMID 7510620. S2CID 46974070. doi:10.2165/00003495-199447010-00003.
Lee YS, Joo MW, Shin SH, Hong S, Chung YG. Current Treatment Concepts for Extra-Abdominal Desmoid-Type Fibromatosis: A Narrative Review. Cancers. January 2024, 16 (2): 273. PMC 10813957 . PMID 38254764. doi:10.3390/cancers16020273 .
Herfarth HH, Long MD, Isaacs KL. Methotrexate: underused and ignored?. Digestive Diseases. 2012, 30 (Suppl 3): 112–8. PMC 4629813 . PMID 23295701. doi:10.1159/000342735.
Boehm IB, Boehm GA, Bauer R. Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int. 1998, 18 (2): 59–62. PMID 9782534. S2CID 25311594. doi:10.1515/cclm.1993.31.10.667.
Paolino A, Alexander H, Broderick C, Flohr C. Non-biologic systemic treatments for atopic dermatitis: Current state of the art and future directions. Clinical and Experimental Allergy. May 2023, 53 (5): 495–510. PMID 36949024. doi:10.1111/cea.14301 .
Flohr C, Rosala-Hallas A, Jones AP, Beattie P, Baron S, Browne F, Brown SJ, Gach JE, Greenblatt D, Hearn R, Hilger E, Esdaile B, Cork MJ, Howard E, Lovgren ML, August S, Ashoor F, Williamson PR, McPherson T, O'Kane D, Ravenscroft J, Shaw L, Sinha MD, Spowart C, Taams LS, Thomas BR, Wan M, Sach TH, Irvine AD. Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial. The British Journal of Dermatology. November 2023, 189 (6): 674–684. PMID 37722926. doi:10.1093/bjd/ljad281.
Eczema in children: uncertainties addressed (报告). NIHR Evidence. 2024-03-19. doi:10.3310/nihrevidence_62438 （英语）.
Mol F, Mol BW, Ankum WM, van der Veen F, Hajenius PJ. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis. Human Reproduction Update. 2008, 14 (4): 309–19. PMID 18522946. doi:10.1093/humupd/dmn012 .
Oliff A, Bleyer WA, Poplack DG. Methotrexate-induced oral mucositis and salivary methotrexate concentrations. Cancer Chemotherapy and Pharmacology. 1979-09-01, 2 (3): 225–226. PMID 313282. S2CID 6273303. doi:10.1007/BF00258300.
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I. Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology. November 2022, 62 (4): 1370–1387. PMC 10070067 . PMID 36318965. doi:10.1093/rheumatology/keac558. 已忽略未知参数|collaboration= (帮助)
Scheinfeld N. Three cases of toxic skin eruptions associated with methotrexate and a compilation of methotrexate-induced skin eruptions. Dermatology Online Journal. December 2006, 12 (7): 15. PMID 17459301. doi:10.5070/D30NQ2C0BX.
Wroński J, Ciechomska M, Kuca-Warnawin E. Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients - Lessons learned from the COVID-19 pandemic. Biomedicine & Pharmacotherapy. September 2023, 165: 115254. PMID 37542854. doi:10.1016/j.biopha.2023.115254 .
Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, Johnson SR, Imundo LF, Winthrop KL, Arasaratnam RJ, Baden LR, Berard R, Bridges SL, Cheah JT, Curtis JR, Ferguson PJ, Hakkarinen I, Onel KB, Schultz G, Sivaraman V, Smith BJ, Sparks JA, Vogel TP, Williams EA, Calabrese C, Cunha JS, Fontanarosa J, Gillispie-Taylor MC, Gkrouzman E, Iyer P, Lakin KS, Legge A, Lo MS, Lockwood MM, Sadun RE, Singh N, Sullivan N, Tam H, Turgunbaev M, Turner AS, Reston J. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care & Research. March 2023, 75 (3): 449–464. PMC 10291822 . PMID 36597813. doi:10.1002/acr.25045.
Al-Haideri MT, Mannani R, Kaboli R, Gharebakhshi F, Darvishzadehdeldari S, Tahmasebi S, Faramarzi F, Cotrina-Aliaga JC, Khorasani S, Alimohammadi M, Darvishi M, Akhavan-Sigari R. The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence. Transplant Immunology. August 2023, 79: 101858. PMC 10205646 . PMID 37236514. doi:10.1016/j.trim.2023.101858.
A pause in methotrexate treatment boosted the immune response to the COVID-19 vaccine. NIHR Evidence (National Institute for Health and Care Research). 2023-01-26. doi:10.3310/nihrevidence_56391.
Imran M, Ali S, Ibrahim AA, Amjad A, Tanveer A, Khalil S, Ali M, Abuelazm M. Effect of methotrexate hold on COVID-19 vaccine response in the patients with autoimmune inflammatory disorders: a systematic review and meta-analysis. Clinical Rheumatology. July 2024, 43 (7): 2203–2214. PMID 38802670. doi:10.1007/s10067-024-07013-3.
Abhishek A, Peckham N, Pade C, Gibbons JM, Cureton L, Francis A, Barber V, Williams JA, Appelbe D, Eldridge L, Julier P, Altmann DM, Bluett J, Brooks T, Coates LC, Rombach I, Semper A, Otter A, Valdes AM, Nguyen-Van-Tam JS, Williams HC, Boyton RJ, McKnight Á, Cook JA. Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. The Lancet. Rheumatology. February 2024, 6 (2): e92–e104. PMID 38267107. doi:10.1016/S2665-9913(23)00298-9.
Rajagopalan PT, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG. Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics. Proceedings of the National Academy of Sciences of the United States of America. October 2002, 99 (21): 13481–6. Bibcode:2002PNAS...9913481R. PMC 129699 . PMID 12359872. doi:10.1073/pnas.172501499 .
Goodsell DS. The molecular perspective: methotrexate. The Oncologist. August 1999, 4 (4): 340–1. PMID 10476546. doi:10.1634/theoncologist.4-4-340 .
Meyer LM, Miller FR, Rowen MJ, Bock G, Rutzky J. Treatment of acute leukemia with amethopterin (4-amino, 10-methyl pteroyl glutamic acid). Acta Haematologica. September 1950, 4 (3): 157–67. PMID 14777272. doi:10.1159/000203749.
Visentin, Michele; Zhao, Rongbao. The Antifolates. ematology/Oncology Clinics of North America. June 2012, 26 (3): 629–ix. [2025-07-06]. doi:10.1016/j.hoc.2012.02.002.
Hertz R, Li MC, Spencer DB. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proceedings of the Society for Experimental Biology and Medicine. November 1956, 93 (2): 361–6. PMID 13379512. S2CID 22939197. doi:10.3181/00379727-93-22757.
Wright JC, Lyons MM, Walker DG, Golomb FM, Gumport SL, Medrek TJ. Observations on the Use of Cancer Chemotherapeutic Agents in Patients With Mycosis Fungoides. Cancer. August 1964, 17 (8): 1045–62. PMID 14202592. doi:10.1002/1097-0142(196408)17:8<1045::AID-CNCR2820170811>3.0.CO;2-S .

drugs.com

Methotrexate. The American Society of Health-System Pharmacists. [2016-08-22]. （原始内容存档于2016-10-08）.

economist.com

Today’s anti-cancer tools are ever better wielded. The Economist. 2017-09-14 [2017-09-16]. （原始内容存档于2018-05-15）.

europa.eu

ema.europa.eu

Jylamvo EPAR. European Medicines Agency. 2017-03-29 [2024-06-25].

harvard.edu

ui.adsabs.harvard.edu

Rajagopalan PT, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG. Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics. Proceedings of the National Academy of Sciences of the United States of America. October 2002, 99 (21): 13481–6. Bibcode:2002PNAS...9913481R. PMC 129699 . PMID 12359872. doi:10.1073/pnas.172501499 .

hu-berlin.de

edoc.hu-berlin.de

Boehm IB, Boehm GA, Bauer R. Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int. 1998, 18 (2): 59–62. PMID 9782534. S2CID 25311594. doi:10.1515/cclm.1993.31.10.667.

mayoclinic.org

Medical abortion. Mayo Clinic. [2022-07-10] （英语）.

medicines.org.uk

Methotrexate 2.5 mg Tablets - Summary of Product Characteristics (SmPC) - (emc). www.medicines.org.uk. [2023-02-19].

medicinescomplete.com

Brayfield A (编). Methotrexate. Martindale: The Complete Drug Reference. Pharmaceutical Press. 2014-01-06 [2014-04-12].

medscape.com

reference.medscape.com

Trexall, Rheumatrex (methotrexate) dosing, indications, interactions, adverse effects, and more. Medscape Reference. WebMD. [2014-04-12]. （原始内容存档于2014-02-08）.

merriam-webster.com

methotrexate. Merriam-Webster Dictionary.

mshpriceguide.org

Methotrexate Sodium. International Drug Price Indicator Guide. [2016-08-23]. （原始内容存档于2019-06-11）.

nice.org.uk

BNF is only available in the UK. NICE. [2023-02-19].

nih.gov

ncbi.nlm.nih.gov

Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis. An update. Drugs. January 1994, 47 (1): 25–50. PMID 7510620. S2CID 46974070. doi:10.2165/00003495-199447010-00003.
Lee YS, Joo MW, Shin SH, Hong S, Chung YG. Current Treatment Concepts for Extra-Abdominal Desmoid-Type Fibromatosis: A Narrative Review. Cancers. January 2024, 16 (2): 273. PMC 10813957 . PMID 38254764. doi:10.3390/cancers16020273 .
Donahue KE, Gartlehner G, Schulman ER, Jonas B, Coker-Schwimmer E, Patel SV, Weber RP, Lohr KN, Bann C, Viswanathan M. Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update. AHRQ Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). 2018. PMID 30199187.
Herfarth HH, Long MD, Isaacs KL. Methotrexate: underused and ignored?. Digestive Diseases. 2012, 30 (Suppl 3): 112–8. PMC 4629813 . PMID 23295701. doi:10.1159/000342735.
Boehm IB, Boehm GA, Bauer R. Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int. 1998, 18 (2): 59–62. PMID 9782534. S2CID 25311594. doi:10.1515/cclm.1993.31.10.667.
Paolino A, Alexander H, Broderick C, Flohr C. Non-biologic systemic treatments for atopic dermatitis: Current state of the art and future directions. Clinical and Experimental Allergy. May 2023, 53 (5): 495–510. PMID 36949024. doi:10.1111/cea.14301 .
Flohr C, Rosala-Hallas A, Jones AP, Beattie P, Baron S, Browne F, Brown SJ, Gach JE, Greenblatt D, Hearn R, Hilger E, Esdaile B, Cork MJ, Howard E, Lovgren ML, August S, Ashoor F, Williamson PR, McPherson T, O'Kane D, Ravenscroft J, Shaw L, Sinha MD, Spowart C, Taams LS, Thomas BR, Wan M, Sach TH, Irvine AD. Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial. The British Journal of Dermatology. November 2023, 189 (6): 674–684. PMID 37722926. doi:10.1093/bjd/ljad281.
Mol F, Mol BW, Ankum WM, van der Veen F, Hajenius PJ. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis. Human Reproduction Update. 2008, 14 (4): 309–19. PMID 18522946. doi:10.1093/humupd/dmn012 .
Oliff A, Bleyer WA, Poplack DG. Methotrexate-induced oral mucositis and salivary methotrexate concentrations. Cancer Chemotherapy and Pharmacology. 1979-09-01, 2 (3): 225–226. PMID 313282. S2CID 6273303. doi:10.1007/BF00258300.
Gromnica-Ihle E, Krüger K. Use of methotrexate in young patients with respect to the reproductive system. Clinical and Experimental Rheumatology. 2010-09-01, 28 (5 Suppl 61): S80–4. PMID 21044438.
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I. Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology. November 2022, 62 (4): 1370–1387. PMC 10070067 . PMID 36318965. doi:10.1093/rheumatology/keac558. 已忽略未知参数|collaboration= (帮助)
Scheinfeld N. Three cases of toxic skin eruptions associated with methotrexate and a compilation of methotrexate-induced skin eruptions. Dermatology Online Journal. December 2006, 12 (7): 15. PMID 17459301. doi:10.5070/D30NQ2C0BX.
Wroński J, Ciechomska M, Kuca-Warnawin E. Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients - Lessons learned from the COVID-19 pandemic. Biomedicine & Pharmacotherapy. September 2023, 165: 115254. PMID 37542854. doi:10.1016/j.biopha.2023.115254 .
Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, Johnson SR, Imundo LF, Winthrop KL, Arasaratnam RJ, Baden LR, Berard R, Bridges SL, Cheah JT, Curtis JR, Ferguson PJ, Hakkarinen I, Onel KB, Schultz G, Sivaraman V, Smith BJ, Sparks JA, Vogel TP, Williams EA, Calabrese C, Cunha JS, Fontanarosa J, Gillispie-Taylor MC, Gkrouzman E, Iyer P, Lakin KS, Legge A, Lo MS, Lockwood MM, Sadun RE, Singh N, Sullivan N, Tam H, Turgunbaev M, Turner AS, Reston J. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care & Research. March 2023, 75 (3): 449–464. PMC 10291822 . PMID 36597813. doi:10.1002/acr.25045.
Al-Haideri MT, Mannani R, Kaboli R, Gharebakhshi F, Darvishzadehdeldari S, Tahmasebi S, Faramarzi F, Cotrina-Aliaga JC, Khorasani S, Alimohammadi M, Darvishi M, Akhavan-Sigari R. The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence. Transplant Immunology. August 2023, 79: 101858. PMC 10205646 . PMID 37236514. doi:10.1016/j.trim.2023.101858.
Imran M, Ali S, Ibrahim AA, Amjad A, Tanveer A, Khalil S, Ali M, Abuelazm M. Effect of methotrexate hold on COVID-19 vaccine response in the patients with autoimmune inflammatory disorders: a systematic review and meta-analysis. Clinical Rheumatology. July 2024, 43 (7): 2203–2214. PMID 38802670. doi:10.1007/s10067-024-07013-3.
Abhishek A, Peckham N, Pade C, Gibbons JM, Cureton L, Francis A, Barber V, Williams JA, Appelbe D, Eldridge L, Julier P, Altmann DM, Bluett J, Brooks T, Coates LC, Rombach I, Semper A, Otter A, Valdes AM, Nguyen-Van-Tam JS, Williams HC, Boyton RJ, McKnight Á, Cook JA. Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. The Lancet. Rheumatology. February 2024, 6 (2): e92–e104. PMID 38267107. doi:10.1016/S2665-9913(23)00298-9.
Rajagopalan PT, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG. Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics. Proceedings of the National Academy of Sciences of the United States of America. October 2002, 99 (21): 13481–6. Bibcode:2002PNAS...9913481R. PMC 129699 . PMID 12359872. doi:10.1073/pnas.172501499 .
Goodsell DS. The molecular perspective: methotrexate. The Oncologist. August 1999, 4 (4): 340–1. PMID 10476546. doi:10.1634/theoncologist.4-4-340 .
Meyer LM, Miller FR, Rowen MJ, Bock G, Rutzky J. Treatment of acute leukemia with amethopterin (4-amino, 10-methyl pteroyl glutamic acid). Acta Haematologica. September 1950, 4 (3): 157–67. PMID 14777272. doi:10.1159/000203749.
Wright JC, Prigot A, Wright B, Weintraub S, Wright LT. An evaluation of folic acid antagonists in adults with neoplastic diseases: a study of 93 patients with incurable neoplasms. Journal of the National Medical Association. July 1951, 43 (4): 211–40. PMC 2616951 . PMID 14850976.
Hertz R, Li MC, Spencer DB. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proceedings of the Society for Experimental Biology and Medicine. November 1956, 93 (2): 361–6. PMID 13379512. S2CID 22939197. doi:10.3181/00379727-93-22757.
Wright JC, Gumport SL, Golomb FM. Remissions produced with the use of Methotrexate in patients with mycosis fungoides. Cancer Chemotherapy Reports. November 1960, 9: 11–20. PMID 13786791.
Wright JC, Lyons MM, Walker DG, Golomb FM, Gumport SL, Medrek TJ. Observations on the Use of Cancer Chemotherapeutic Agents in Patients With Mycosis Fungoides. Cancer. August 1964, 17 (8): 1045–62. PMID 14202592. doi:10.1002/1097-0142(196408)17:8<1045::AID-CNCR2820170811>3.0.CO;2-S .

pmc.ncbi.nlm.nih.gov

Visentin, Michele; Zhao, Rongbao. The Antifolates. ematology/Oncology Clinics of North America. June 2012, 26 (3): 629–ix. [2025-07-06]. doi:10.1016/j.hoc.2012.02.002.

nihr.ac.uk

evidence.nihr.ac.uk

Eczema in children: uncertainties addressed (报告). NIHR Evidence. 2024-03-19. doi:10.3310/nihrevidence_62438 （英语）.
A pause in methotrexate treatment boosted the immune response to the COVID-19 vaccine. NIHR Evidence (National Institute for Health and Care Research). 2023-01-26. doi:10.3310/nihrevidence_56391.

oxforddictionaries.com

methotrexate – definition of methotrexate in English from the Oxford dictionary. OxfordDictionaries.com. [2016-01-20]. （原始内容存档于2012-10-22）.

semanticscholar.org

api.semanticscholar.org

Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis. An update. Drugs. January 1994, 47 (1): 25–50. PMID 7510620. S2CID 46974070. doi:10.2165/00003495-199447010-00003.
Boehm IB, Boehm GA, Bauer R. Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int. 1998, 18 (2): 59–62. PMID 9782534. S2CID 25311594. doi:10.1515/cclm.1993.31.10.667.
Oliff A, Bleyer WA, Poplack DG. Methotrexate-induced oral mucositis and salivary methotrexate concentrations. Cancer Chemotherapy and Pharmacology. 1979-09-01, 2 (3): 225–226. PMID 313282. S2CID 6273303. doi:10.1007/BF00258300.
Hertz R, Li MC, Spencer DB. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proceedings of the Society for Experimental Biology and Medicine. November 1956, 93 (2): 361–6. PMID 13379512. S2CID 22939197. doi:10.3181/00379727-93-22757.

versusarthritis.org

Methotrexate. Versus Arthritis. [2023-02-19] （英国英语）.

web.archive.org

methotrexate – definition of methotrexate in English from the Oxford dictionary. OxfordDictionaries.com. [2016-01-20]. （原始内容存档于2012-10-22）.
Methotrexate. The American Society of Health-System Pharmacists. [2016-08-22]. （原始内容存档于2016-10-08）.
Trexall, Rheumatrex (methotrexate) dosing, indications, interactions, adverse effects, and more. Medscape Reference. WebMD. [2014-04-12]. （原始内容存档于2014-02-08）.
Sneader, Walter. Drug Discovery: A History. John Wiley & Sons. 2005: 251. ISBN 9780470015520. （原始内容存档于2017-02-16）（英语）.
Today’s anti-cancer tools are ever better wielded. The Economist. 2017-09-14 [2017-09-16]. （原始内容存档于2018-05-15）.
WHO Model List of Essential Medicines (19th List) (PDF). World Health Organization. April 2015 [2016-12-08]. （原始内容存档 (PDF)于2016-12-13）.
Methotrexate Sodium. International Drug Price Indicator Guide. [2016-08-23]. （原始内容存档于2019-06-11）.

who.int

WHO Model List of Essential Medicines (19th List) (PDF). World Health Organization. April 2015 [2016-12-08]. （原始内容存档 (PDF)于2016-12-13）.